Construction and characterization of a stable full-length macrophage-tropic HIV type 1 molecular clone that directs the production of high titers of progeny virions.
about
Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway.HIV-1 Vpu targets cell surface markers CD4 and BST-2 through distinct mechanismsSmall interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral productionAllosteric modulation of the HIV-1 gp120-gp41 association site by adjacent gp120 variable region 1 (V1) N-glycans linked to neutralization sensitivityCCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infectionVpu and BST2: Still Not There Yet?HIV-1 infection of T cells and macrophages are differentially modulated by virion-associated Hck: a Nef-dependent phenomenonPandemic HIV-1 Vpu overcomes intrinsic herd immunity mediated by tetherin.Conditional reduction of human immunodeficiency virus type 1 replication by a gain-of-herpes simplex virus 1 thymidine kinase function.Evolution of a human immunodeficiency virus type 1 variant with enhanced replication in pig-tailed macaque cells by DNA shufflingImproving the estimation of the death rate of infected cells from time course data during the acute phase of virus infections: application to acute HIV-1 infection in a humanized mouse model.The valine-to-threonine 75 substitution in human immunodeficiency virus type 1 reverse transcriptase and its relation with stavudine resistance.HIV-1 activates macrophages independent of Toll-like receptors.Δ(9)-Tetrahydrocannabinol treatment during human monocyte differentiation reduces macrophage susceptibility to HIV-1 infectionRegulation of virus release by the macrophage-tropic human immunodeficiency virus type 1 AD8 isolate is redundant and can be controlled by either Vpu or Env.Effect of mutations in the human immunodeficiency virus type 1 protease on cleavage of the gp41 cytoplasmic tail.HIV-1 competition experiments in humanized mice show that APOBEC3H imposes selective pressure and promotes virus adaptationIdentification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4Differentiation of promonocytic U937 subclones into macrophagelike phenotypes regulates a cellular factor(s) which modulates fusion/entry of macrophagetropic human immunodeficiency virus type 1.Mutations in both gp120 and gp41 are responsible for the broad neutralization resistance of variant human immunodeficiency virus type 1 MN to antibodies directed at V3 and non-V3 epitopes.Generation of the pathogenic R5-tropic simian/human immunodeficiency virus SHIVAD8 by serial passaging in rhesus macaquesNF-kappaB cis-acting motifs of the human immunodeficiency virus (HIV) long terminal repeat regulate HIV transcription in human macrophages.A Conserved Target Site in HIV-1 Gag RNA is Accessible to Inhibition by Both an HDV Ribozyme and a Short Hairpin RNAGPI-anchored single chain Fv--an effective way to capture transiently-exposed neutralization epitopes on HIV-1 envelope spike.R5 variants of human immunodeficiency virus type 1 preferentially infect CD62L- CD4+ T cells and are potentially resistant to nucleoside reverse transcriptase inhibitorsSelectively reduced tat mRNA heralds the decline in productive human immunodeficiency virus type 1 infection in monocyte-derived macrophages.The interferon-inducible host factor bone marrow stromal antigen 2/tetherin restricts virion release, but is it actually a viral restriction factor?A diagnostic HIV-1 tropism system based on sequence relatedness.Inhibition of HIV-1 infection by aqueous extracts of Prunella vulgaris LHIV-1 escape from the CCR5 antagonist maraviroc associated with an altered and less-efficient mechanism of gp120-CCR5 engagement that attenuates macrophage tropismPotent and broad anti-HIV-1 activity exhibited by a glycosyl-phosphatidylinositol-anchored peptide derived from the CDR H3 of broadly neutralizing antibody PG16.Some human immunodeficiency virus type 1 Vpu proteins are able to antagonize macaque BST-2 in vitro and in vivo: Vpu-negative simian-human immunodeficiency viruses are attenuated in vivo.Antibody-mediated enhancement of HIV-1 and HIV-2 production from BST-2/tetherin-positive cells.Rev-dependent lentiviral expression vectorNoninfectious papilloma virus-like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27.The W100 pocket on HIV-1 gp120 penetrated by b12 is not a target for other CD4bs monoclonal antibodiesRole for the terminal clasp of HIV-1 gp41 glycoprotein in the initiation of membrane fusionDifferential glycosylation, virion incorporation, and sensitivity to neutralizing antibodies of human immunodeficiency virus type 1 envelope produced from infected primary T-lymphocyte and macrophage culturesInfection of chimpanzee peripheral blood mononuclear cells by human immunodeficiency virus type 1 requires cooperative interaction between multiple variable regions of gp120Vpu augments the initial burst phase of HIV-1 propagation and downregulates BST2 and CD4 in humanized mice.
P2860
Q24523390-C9C18A13-257E-4784-A9A9-E7C241265F20Q24619066-A374E9EC-7964-4E3C-865C-0880AF779B42Q24682936-1B3E84E7-3E92-42EC-885B-B820C5290E7AQ28485983-86831EDC-39B2-4221-9561-C0D1F914AB52Q28542878-499A6AD5-3940-4BDC-B16E-3FF046962F6AQ28730708-1FA3431C-AE1F-4CAC-ABF9-10EBB11D017BQ30009553-9FED574A-16D3-4CA8-8629-3928D90565A9Q30376824-85A22CE5-296D-4A64-A2CC-E5C5D385475AQ30424775-3EDB50B9-E728-49E1-A12B-D5B04D443078Q30818112-4FB6C627-AC38-43C2-B748-EF9D96304D30Q30828221-2A451D7D-33B0-4D09-8A2F-9DEB79D805B3Q31779475-85600C96-25E1-43EC-A9D7-C82AB4EF9897Q33388690-4AAF2237-ED39-4308-9B31-6C3863348988Q33605261-3DAF808B-4FFB-4CFF-A8A4-1482BBE25450Q33640055-9ACDD72E-AB51-4919-BAD7-AD898E37074EQ33676508-618061F0-B85E-4CC9-981E-BCECF3A476B3Q33699581-DF34CC3D-0D04-479D-AC59-A97A4F342FB4Q33782530-5636744F-F88D-442E-92A4-41E5AA325087Q33783481-767CA765-E402-483A-B6BB-B33173CD5769Q33783763-E6F32AE3-BCE9-4BBB-BC0D-65C4C3F3D2A5Q33826773-B083D509-70C8-495E-A62E-10526AD322C6Q33849726-AAC8B054-09C5-4E89-A840-0656E3D7825CQ34001054-24D448C6-FFD1-4D67-8609-8F2DA91C0FEBQ34221625-0013FF4F-6FB3-4535-9223-0161EF103D82Q34301688-1E4254F2-5C93-4A75-BC9A-C06702B30C55Q34351941-65311240-EC9B-4357-B4CB-2F8E4B43EFB8Q34492477-EF49E4EF-3A62-40E0-B938-491924F21BC5Q34983107-2415C8E0-F740-4725-988A-2DD8977FF990Q34988956-9FEED193-D416-474B-841C-B39579B83DB6Q35076868-4A56F9A1-B16F-4350-A11C-E5D1A8714CC8Q35192886-23B29538-E28B-4EBD-AEDF-C7E89BE79E29Q35383070-B66BDA58-3A7D-42E9-B4CE-0BDC327E45DFQ35531194-0EC0A810-0A9F-45CD-AB49-684D94D8117DQ35634169-C7585301-2811-43A9-B56D-160EF1EFA7D9Q35642774-5EA8235F-1579-4ADD-A0CF-DCD4AB014A41Q35799529-F62B7055-7741-43FD-8B23-057740BEFB9BQ35842116-89BDFD60-2E18-46F7-B052-4B9651080BB9Q35868854-78684AD2-6339-4DCC-98F1-640F3A26E299Q35871391-C901ECCB-B6E6-40B4-AA3C-F9345673C0F1Q35943823-1466AA2E-CB26-4B11-819A-2E4782F4ADEE
P2860
Construction and characterization of a stable full-length macrophage-tropic HIV type 1 molecular clone that directs the production of high titers of progeny virions.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Construction and characterizat ...... igh titers of progeny virions.
@en
Construction and characterizat ...... igh titers of progeny virions.
@nl
type
label
Construction and characterizat ...... igh titers of progeny virions.
@en
Construction and characterizat ...... igh titers of progeny virions.
@nl
prefLabel
Construction and characterizat ...... igh titers of progeny virions.
@en
Construction and characterizat ...... igh titers of progeny virions.
@nl
P2093
P356
P1476
Construction and characterizat ...... igh titers of progeny virions.
@en
P2093
Buckler CE
Buckler-White A
Theodore TS
P304
P356
10.1089/AID.1996.12.191
P577
1996-02-01T00:00:00Z